A number of studies have shown beneficial effects of GLP-1-based interventions on measures affecting cardiovascular pathologies such as blood pressure, body weight, and lipid metabolism that are thought to be exerted independent of GLP-1 analogue’s effects on glycemic control8, 9 and the effects on markers of atherosclerosis are also reported10, 11, 12. The gene discussed is GCG; the disease is atherosclerosis.